CATS Cell-Based Assay for Detecting Weak TCR-pMHC Interactions

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current tetramer molecules are costly and ineffective in identifying weak TCR-pMHC interactions, limiting the study of crucial immune responses and being difficult to generate, especially for immunodominant West Nile Virus epitopes.

Innovation Solution

The Coupling Assay for T cell Specificity (CATS) uses MHC molecule-expressing cell lines with tethered peptides to increase avidity, allowing detection of weak TCR-pMHC interactions through M12 and 58α−β− hybridoma cell lines.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If tetramer molecules are used to identify TCR-pMHC interactions, then strong interactions can be detected with high specificity, but weak interactions remain undetected and the method is costly

Engineering Contradiction:

Improvedetection sensitivityVSAvoidmethod complexity

Core Design Contradiction:

Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the detection system into two functional components: (1) MHC molecule-expressing cell lines that present peptide antigens, and (2) antigen-specific T cells that recognize the pMHC complex. This segmentation allows the system to detect weak TCR-pMHC interactions by separating the detection function from the presentation function, enabling more sensitive measurement compared to tetramer methods

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent introduces MHC molecule-expressing cell lines as an intermediary system between the TCR and the detection mechanism. These cell lines present peptides in a physiological context, serving as a mediator that enables detection of weak interactions through natural TCR-pMHC binding events rather than forced tetramer-TCR engagement

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If tetramer molecules are used to increase avidity for detection, then T cell-pMHC interactions become observable, but the method becomes costly and difficult to generate

Engineering Contradiction:

Improveinteraction detection reliabilityVSAvoidmethod ease of manufacture

Core Design Contradiction:

ReliabilityVSEase of manufacture

Solution Approach 1:

The MHC molecule-expressing cell lines serve themselves by naturally presenting peptides through their endogenous MHC molecules. The system utilizes the cell's own biological machinery to display antigens, eliminating the need for external tetramer preparation and enabling reliable detection of T cell responses without complex manufacturing requirements

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The patent changes the detection parameter from measuring direct TCR-tetramer binding to measuring T cell coupling with MHC molecule-expressing cell lines. This parameter change enables detection of weak interactions by measuring the functional outcome of TCR-pMHC binding in a physiological context, improving reliability while simplifying the overall method

Inventive Principle:

Principle #35Parameter changes

3Productivity

If standard T cell assays are used to characterize T cell responses, then general T cell function can be measured, but antigen-specific T cells with weak binding are difficult to observe

Engineering Contradiction:

ImproveT cell response characterization efficiencyVSAvoidspecific T cell detection sensitivity

Core Design Contradiction:

ProductivityVSMeasurement precision

Solution Approach 1:

The MHC molecule-expressing cell lines serve multiple functions: they present specific peptide antigens to activate antigen-specific T cells, provide a physiological platform for TCR-pMHC interaction, and enable flow cytometric detection of T cell coupling. This multi-functionality allows simultaneous characterization of T cell responses with both efficiency and high sensitivity for weak binders

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

CATS provides a more affordable and sensitive method to identify antigen-specific T cells, overcoming limitations of tetramers by detecting weak interactions and expanding knowledge of T cell responses.

Implementation Method 1

T cells use their T cell receptors (TCRs) to survey peptide antigens attached to class I or class II major histocompatibility complex (pMHC-I or pMHC-II) molecules on antigen-presenting cells (APCs)

Methodology Applied

Scientific EffectT cell receptor recognition:

Implementation Method 2

The KD of biotin and streptavidin is 10−15 M, which indicates a high affinity for one another. These streptavidin proteins are also conjugated to a fluorescent protein so that tetramer engagement to a T cell may be measured on a flow cytometer

Methodology Applied

Scientific EffectHigh affinity binding:

Data Source

PatentUS20250231186A1Coupling assay for t cell specificity (CATS) and method of its use

Publication Date: 2025.07.17 THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA

AI summary

A technique, called the Coupling Assay for T-cell Specificity (CATS), to identify antigen-specific cells using cell lines expressing MHC II molecules with tethered peptides. CATS successfully identified antigen-specific T cells with a low-affinity peptide, while tetramer failed to identify cells with this same peptide. Increasing avidity on artificial antigen presenting cells can overcome low affinity TCR-pMHC interactions, can identify more responding endogenous populations, and may be specific for the MHCII.